Replimune Group バランスシートの健全性
財務の健全性 基準チェック /56
Replimune Groupの総株主資本は$381.5M 、総負債は$45.6Mで、負債比率は11.9%となります。総資産と総負債はそれぞれ$498.2Mと$116.7Mです。
主要情報
11.9%
負債資本比率
US$45.57m
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | US$432.06m |
| エクイティ | US$381.46m |
| 負債合計 | US$116.74m |
| 総資産 | US$498.20m |
財務の健全性に関する最新情報
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23
Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Recent updates
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23Replimune: Strong Data In A Highly Differentiated Space
Sep 03Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune: Continuing To Justify The Bear Thesis (For Now)
May 22Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer
Jan 23Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)
Dec 25Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Jan 06Replimune secures $200M term loan
Oct 07Replimune: Recent Developments Strengthen Bull Thesis
Aug 12Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Replimune Group GAAP EPS of -$0.78 misses by $0.15
Aug 04Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate
Jun 24We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate
Apr 04Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth
Dec 16Replimune: In The 'Buy Zone' Again
Oct 01Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Sep 02Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business
May 24Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic
Apr 30We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow
Feb 08Replimune Group EPS misses by $0.03
Feb 04Dosing underway in Replimune's early-stage cancer study with gene therapy
Jan 05財務状況分析
短期負債: REPLの 短期資産 ( $442.6M ) が 短期負債 ( $43.8M ) を超えています。
長期負債: REPLの短期資産 ( $442.6M ) が 長期負債 ( $73.0M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: REPL総負債よりも多くの現金を保有しています。
負債の削減: REPLの負債対資本比率は、過去 5 年間で8%から11.9%に増加しました。
貸借対照表
キャッシュ・ランウェイ分析
過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。
安定したキャッシュランウェイ: REPLは、現在の フリーキャッシュフロー に基づき、1 年以上にわたって十分な キャッシュランウェイ を有しています。
キャッシュランウェイの予測: REPLは、フリー キャッシュ フローが毎年30 % の歴史的率で減少し続ける場合、 2.1年間十分なキャッシュ ランウェイを有しています。